APA (7th ed.) Citation

A, B., J, Z., J, E., & JR, A. (2024). Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: A case series. Pediatric hematology and oncology, 41(6), 389. https://doi.org/10.1080/08880018.2024.2350455

Chicago Style (17th ed.) Citation

A, Bowden, Zambito J, El-Feghaly J, and Andolina JR. "Adjuvant Immune Checkpoint Inhibitor Therapy May Benefit Pediatric Patients with Stage III Melanoma and Sentinel Lymph Node Positivity: A Case Series." Pediatric Hematology and Oncology 41, no. 6 (2024): 389. https://doi.org/10.1080/08880018.2024.2350455.

MLA (9th ed.) Citation

A, Bowden, et al. "Adjuvant Immune Checkpoint Inhibitor Therapy May Benefit Pediatric Patients with Stage III Melanoma and Sentinel Lymph Node Positivity: A Case Series." Pediatric Hematology and Oncology, vol. 41, no. 6, 2024, p. 389, https://doi.org/10.1080/08880018.2024.2350455.